Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D as Adjuvant Therapy for Severe Atopic Dermatitis
NCT04468711Phase 3Completed
- Sponsor
- National Hepatology and Tropical Medicine Research Institute
- Start
- Jun 2018
- Primary completion
- Dec 2018
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in atopic dermatitis (AD) comparing Vitamin D Group with Placebo Group (2 arms). Primary endpoints: Eczema Area and Severity Index at 12 weeks and Eczema Area and Severity Index percent change at 12 weeks. Started Jun 2018; status: completed.
02
Drugs
vitamin d
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT04468711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04468711.